Practice Areas

Abbreviated New Drug Application (ANDA) Litigation

In order for a generic drug pharmaceutical manufacturer to enter the market before the expiration of a patent covering an FDA-approved drug or method of treatment, it must file an Abbreviated New Drug Application (ANDA) and a Paragraph IV certification under the Hatch-Waxman Act. The certification alleges that the applicable patent listed in the FDA’s list entitled “Approved Drug Products with Therapeutic Equivalence Evaluations,” the so-called Orange Book, is invalid

Post Grant Proceedings

Aside from litigation before the federal district courts, the validity of granted U.S. patents may be challenged before the U.S. Patent and Trademark Office. Post grant proceedings are in fact a changing and vibrant area of patent law, as the America Invents Act (AIA)  has changed the landscape for such post grant challenges. Following AIA, the collection of post grant proceedings used to effect patent validity challenges comprises Ex Parte

Business and Tort Litigation

In an increasingly litigious business environment, our clients are faced an array of potential controversies. Advances in modern types and storage of electronic communications, as well as in electronic discovery techniques, have increased the complexity of litigations and sped the progression of pending cases. Previously mundane commercial disputes have become extremely contentious, with adversaries rooting through millions of emails and electronic documents. A few areas of rapid expansion in filings

Litigation and Appeals

IPLL’s Litigation and Appeals practice is a leader across the business and technology sectors. Our attorneys possessing a long track record of achievement in complex commercial disputes, where the stakes are exceedingly high. We also bring exceptional industry knowledge and provide leading edge advice. With experienced trial and appellate lawyers, we litigate and win commercial disputes across multiple industries and geographies. Our value proposition is a holistic approach combined with

ITC Section 337 Litigation

While Section 337 investigations at the U.S. International Trade Commission (ITC) are not known in common parlance, they are all too familiar to multinational corporations. The ITC has the power to order U.S. Customs and Border Protection to exclude the infringing articles from entry into the U.S., and may also issue a cease and desist order prohibiting the respondent from selling infringing articles that have already been imported. For this

Patent Litigation

Building on a reputation for the highest quality first chair patent litigators, and working in cooperation with nationally known litigators serving as our local counsel, IPLL brings extensive expertise in handling complex patent litigations, as well as mediation, arbitration, and other forms of dispute resolution. IPLL’s patent litigators themselves possess advanced technology degrees and industry experience, and collaborate with experts across multiple industries, including Biotechnology, Chemical, Clean and Green Technology,

Strategic IP Counseling

IPLL evaluates the business strength of technologies through market segmentation and detailed analyses of relevant systems, products and employed methodologies. We employ the services of leading experts in the relevant technologies as well as experts in damages. In the high technology area, representative industries include electronics, telecommunications, Internet, software, computer hardware, financial services, semiconductors and optical systems. In the sciences industries, representative industries include biotechnology, medical devices and pharmaceuticals. Our

America Invents Act

The Leahy-Smith America Invents Act (AIA) became law on September 16, 2011, and represents the most comprehensive overhaul of the United States patent system since the Patent Act was enacted in 1952. AIA includes numerous provisions impacting patent litigation, licensing and enforcement, and the provisions become individually effective over the span of several years. With attorneys having many decades of patent prosecution, licensing and litigation experience, IPLL is uniquely qualified

Life Sciences

Rapid technical advances and an increasing regulatory burden pose opportunities and challenges for the life science industry. Combining legal and technological expertise, IPLL’s experienced attorneys help clients succeed in this changing industry environment across all relevant disciplines. With a clear understanding of how patents fit into a company’s overall business model and commercial strategy, IPLL assists clients with developing and monetizing their patent portfolios, creating an IP strategy that aligns


IPLL’s Corporate Practice Area is comprised of attorneys and legal assistants who have established a national reputation for excellence in the quality and delivery of legal services. Our counsel have represented clients from nearly every type of high technology and biotechnology focused industry, form of legal structure and venue for business transactions.Yet our counsel share in common the commitment to meet the full legal needs of every client, regardless of